• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Unicycive Therapeutics Inc (NQ: UNCY )

    0.4551 -0.0049 (-1.07%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Unicycive Therapeutics Inc

    < Previous 1 2 3 4 5 6 7 Next >
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
    Gainers Barnes & Noble Education, Inc. (NYSE: BNED) rose 25% to $2.15 in pre-market trading after the company posted better-than-expected quarterly sales. 
    Via Benzinga
    Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers 
    Via Benzinga
    Looking Into Unicycive Therapeutics's Recent Short Interest
    Via Benzinga
    Unicycive: The Company Developing Key Kidney Therapies
    by\nJohnny Rice, Benzinga Contributor 
    Via News Direct
    Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
    Via Benzinga
    BioMedNewsBreaks – Unicycive Therapeutics Inc. (NASDAQ: UNCY) Announces up to $130M to Commercialize and Launch Investigational New Drug
    Via Investor Brand Network
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Unicycive: The Company Developing Key Kidney Therapies
    Doug Jermasek, Executive Vice President, Corporate Strategy for Unicycive Therapeutics, Inc. (NASDAQ: UNCY), was recently interviewed by Benzinga. 
    Via TheNewswire.com
    Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Dow Tumbles 250 Points Following Powell's Comments; Crude Oil Down 2%
    U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday. The Dow traded down 0.77% to 33,172.39 while the NASDAQ fell 0.72% to 11,591.36. The S&P 500... 
    Via Benzinga
    The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
    By Julian Richard, Benzinga 
    Via TheNewswire.com
    The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
    The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury 
    Via News Direct
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Nasdaq Rises 50 Points; Ciena Earnings Top Expectations
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday. The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P... 
    Via Benzinga
    Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher
    U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500... 
    Via Benzinga
    Why Unicycive Therapeutics Stock Is Exploding Higher Monday
    Unicycive Therapeutics Inc (NASDAQ: UNCY) shares are exploding higher Monday after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
    Unicycive Therapeutics Inc (NASDAQ: UNCY) is a biopharmaceutical company spearheading efforts to develop effective, safe, and novel treatments for kidney disease to improve patient and caregiver... 
    Via Benzinga
    Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
    Via Benzinga
    Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
    From Unicycive Therapeutics, Inc.
    Via GlobeNewswire
    The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
    By Julian Richard, Benzinga 
    Via TheNewswire.com
    The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
    The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers 
    Via News Direct
    The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
    Unicycive Therapeutics Inc (NASDAQ: UNCY) is a biopharmaceutical company committed to developing effective and safe treatments for kidney (renal) disease to reduce death rates and improve patients and... 
    Via Benzinga
    Unicycive to Highlight Potential of UNI-494 to Restore Mitochondrial Function and Reduce Oxidative Stress at Two Upcoming Medical and Scientific Meetings
    From Unicycive Therapeutics, Inc.
    Via GlobeNewswire
    Unicycive: The Company Developing Key Kidney Therapies
    Doug Jermasek, Executive Vice President, Corporate Strategy for Unicycive Therapeutics, Inc. (NASDAQ: UNCY), was recently interviewed by Benzinga. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.